1. Home
  2. VYGR vs AISP Comparison

VYGR vs AISP Comparison

Compare VYGR & AISP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • AISP
  • Stock Information
  • Founded
  • VYGR 2013
  • AISP 2006
  • Country
  • VYGR United States
  • AISP United States
  • Employees
  • VYGR N/A
  • AISP N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • AISP Blank Checks
  • Sector
  • VYGR Health Care
  • AISP Finance
  • Exchange
  • VYGR Nasdaq
  • AISP Nasdaq
  • Market Cap
  • VYGR 231.9M
  • AISP 186.4M
  • IPO Year
  • VYGR 2015
  • AISP N/A
  • Fundamental
  • Price
  • VYGR $4.69
  • AISP $6.53
  • Analyst Decision
  • VYGR Strong Buy
  • AISP Strong Buy
  • Analyst Count
  • VYGR 8
  • AISP 1
  • Target Price
  • VYGR $16.71
  • AISP $6.00
  • AVG Volume (30 Days)
  • VYGR 789.3K
  • AISP 1.4M
  • Earning Date
  • VYGR 11-11-2025
  • AISP 11-13-2025
  • Dividend Yield
  • VYGR N/A
  • AISP N/A
  • EPS Growth
  • VYGR N/A
  • AISP N/A
  • EPS
  • VYGR N/A
  • AISP N/A
  • Revenue
  • VYGR $42,580,000.00
  • AISP $13,724,085.00
  • Revenue This Year
  • VYGR N/A
  • AISP $34.52
  • Revenue Next Year
  • VYGR $107.10
  • AISP $59.54
  • P/E Ratio
  • VYGR N/A
  • AISP N/A
  • Revenue Growth
  • VYGR N/A
  • AISP N/A
  • 52 Week Low
  • VYGR $2.65
  • AISP $1.90
  • 52 Week High
  • VYGR $8.28
  • AISP $7.66
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 62.56
  • AISP 66.08
  • Support Level
  • VYGR $4.32
  • AISP $5.02
  • Resistance Level
  • VYGR $5.06
  • AISP $7.20
  • Average True Range (ATR)
  • VYGR 0.29
  • AISP 0.46
  • MACD
  • VYGR 0.02
  • AISP 0.15
  • Stochastic Oscillator
  • VYGR 64.59
  • AISP 73.16

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture.

Share on Social Networks: